Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas
Crossref DOI link: https://doi.org/10.1186/s12885-015-1267-0
Published Online: 2015-04-12
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gao, Hua
Wang, Fei
Lan, Xiaolei
Li, Chuzhong
Feng, Jie
Bai, Jiwei
Cao, Lei
Gui, Songbai
Hong, Lichuan
Zhang, Yazhuo
License valid from 2015-04-12
Article History
Received: 8 July 2014
Accepted: 25 March 2015
First Online: 12 April 2015